Three new GLP-1 studies, why every food is suddenly "high protein," the Bethenny Frankel shoe drama blowing up Instagram, and why I'm on a ketamine table as you listen.
Three new studies just shifted the GLP-1 conversation, and not in the direction women have been hearing about. Chalene digs into what's actually happening to muscle and bone density, why the rebound after coming off matters more than anyone's talking about, and the three questions every woman on Ozempic, Wegovy, Mounjaro, or Zepbound should bring to her next doctor's appointment.
She also gets into why every grocery aisle suddenly screams "high protein," and why this whole moment is starting to feel suspiciously like the Snackwell cookie era. There's a simple protein target that works without tracking macros, and Chalene walks through how she's using it.
Then she breaks down the Bethenny Frankel shoe drama that took over Instagram this week. What the shoe brand founder got wrong, what Bethenny got wrong, and the rules of brand partnerships that almost nobody outside the influencer world understands.
Finally, a personal update. As you're listening to this, Chalene is on the table for another medically supervised ketamine treatment with Dr. Andrew Levinson. She shares why she went back for a third session, what the last journey taught her about control, and who this kind of work is really for.
🔥Join Chalene on her private podcast 👉http://chalene.com/more
🎯 Need a clinician who is trained in women's health and accepts insurance? Book your virtual visit today with MIDI Health! 👉http://chalene.com/midi
🎉 Camp Be More 2027 Registration is now OPEN!! 👉 http://campbemore.com
🎯Treat yourself to the best bra and shapewear on the market and save 20% Off your entire order at honeylove.com/CHALENE
🤓 Studies:
March 2026 — Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
https://pubmed.ncbi.nlm.nih.gov/41850248/
March 2026 — Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health
https://aaos-annualmeeting-presskit.org/2026/research-news/studies-explore-glp-1-receptor-agonist-use-and-its-impact-on-long-term-musculoskeletal-health/
May 2026 — Muscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational study
https://www.sciencedirect.com/science/article/pii/S0261561426000476
April 2026 — GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling
https://pubmed.ncbi.nlm.nih.gov/41998799/
🔥Join Phase It!! Simplifies the art of aging vibrantly with science-backed fitness, nutrition and hormone support programs that actually work! https://phaseitup.com/
Join the PodSquad on Facebook! 👉https://www.facebook.com/groups/ChalenePodSquad
🧐Sign Up to Get the Weekly Newsletter!! 👉https://chalene.com/newsletter/
We would love to hear from you! Leave your questions or messages for Chalene RIGHT HERE
To advertise on our podcast, please reach out to thechaleneshow@gmail.com and mention The Chalene Show
Connect with me on your fav social platform:
